Skip to main content
✦Prime Rate:7.00%✦Fed Funds:3.88%✦5 Yr Treasury:4.95%↓✦10 Yr Treasury:5.10%↓✦30 Yr Treasury:5.43%↓✦30 Yr Mortgage:7.11%·Updated Nov 12, 2026✦Prime Rate:7.00%✦Fed Funds:3.88%✦5 Yr Treasury:4.95%↓✦10 Yr Treasury:5.10%↓✦30 Yr Treasury:5.43%↓✦30 Yr Mortgage:7.11%·Updated Nov 12, 2026
Rates
Vital Care Infusion Services

Vital Care Infusion Services

The total investment to open a Vital Care Infusion Services franchise ranges from $555,750 to $1.0M. The initial franchise fee is $60,000. Ongoing royalties are 5% plus a 1% advertising fee.

What is the Vital Care Infusion Services franchise?

Vital Care Infusion Services was founded in 1986 by Johnny Bell, a consultant pharmacist who saw the value of providing complex infusion therapies outside conventional hospitals. The company delivers home and alternate site infusion therapy through locally owned and operated pharmacies across the United States. As of August 2024, it had more than 160 infusion pharmacy locations across 35 states. Other undated reports cite over 160 and over 165 infusion pharmacy franchises. The 2024 Franchise Disclosure Document reported 74 franchised locations and 2 corporate locations, for 76 total units, while a January 2024 report cited 73 franchise locations. The brand operates only in the United States and is described as the fastest growing infusion pharmacy franchise in the nation.

Home and alternate site infusion therapy benefits from increased demand for convenient care, an aging population, chronic and complex medical needs, and advances that allow more therapies outside hospitals. Services can include antibiotics, antifungals, immunotherapies, and nutritional support. Home care may lower costs while improving comfort and adherence. Essential medical services can also remain in demand during economic downturns. Vital Care is expanding into targeted and underserved U.S. markets through locally owned pharmacies, with a focus on community based service. Its position in a fragmented healthcare sector reflects the growing need for accessible infusion care.

The investment is positioned as a mid to high tier healthcare franchise. Reported initial franchise fees include $60,000, up to $60,000, $50,000 as of January 2024, $25,000 to $50,000 under the 2022 FDD paid to the franchisor or an affiliate, and $40,000 in an older FDD. Reported total initial investment ranges include $556,000 to $1,006,000, $555,750 to $1,005,735 under FDD Item 7, $545,850 to $1,005,385, $536,000 to $995,000 as of January 2024, $488,530 to $982,130 under the 2022 FDD, and $497,000 to $706,200 in an undated source. Costs include leasehold improvements, equipment, inventory, working capital, and other startup needs. Additional funds for six months are estimated at $274,000 to $367,000, with minimum cash required of $135,000. As of October 2025, the royalty is 5% of gross sales. Historical reports cite 1.75% to 19.25%, 19.0%, and 3% to 19%. Advertising is listed at 2.00%, while the October 2025 marketing fee is 1% of gross sales. In August 2024, Berkshire Partners and Leonard Green & Partners announced a strategic investment. Linden Capital Partners, an investor since 2020, remains involved alongside management and the Bell family.

The operating model combines patient care in homes and alternate site locations with a physical pharmacy for compounding, storage, and administrative work. Activities include patient intake, provider coordination, medication compounding and dispensing, infusion scheduling, treatment delivery, and regulatory compliance. Pharmacists and nurses are central to service delivery, which helps explain the brand's interest in experienced pharmacists and healthcare executives. Vital Care provides training covering operational and clinical knowledge, although the source does not provide its length or location. Corporate support includes field consultants, technology for patient management and compliance, marketing programs, and supply chain relationships for medications and equipment. The brand has a presence in the Southeast and Texas, with notable concentrations in Georgia, North Carolina, and South Carolina, and seeks pharmacies in targeted and underserved U.S. markets. It encourages multi unit ownership, while the clinical nature of the business suggests substantial owner involvement.

Vital Care appeared on the Inc. 5000 list at No. 1872 in 2025, with 232% three year growth, and also appeared in 2024 at No. 2377, 2023 at No. 3037, and 2021 at No. 2259.

Vital Care grew from over 60 franchised pharmacies across two dozen states in August 2021 to over 65 infusion pharmacy franchises in approximately two dozen states by January 2023. The 2024 FDD reported 74 franchised locations and 2 corporate locations, for 76 units, while another January 2024 report cited 73 franchise locations. August 2024 information reported more than 160 locations across 35 states, with undated sources citing over 160 and over 165 franchises. The company opened six locations in 2020 and planned more than five in 2021. In August 2021, it signed nine franchise agreements covering Arkansas, Florida, Texas, South Carolina, Kansas, Georgia, and Pennsylvania. The August 2024 investment from Berkshire Partners and Leonard Green & Partners added to the involvement of Linden Capital Partners, which has invested since 2020. Leadership includes CEO and President Steve Foreman, also called Stephen Foreman, Brett Dethmers, John King, Mike Kirkbride, Logan Davis, Mark Flexsenhar, and Chris Newlin. Their titles are Chief Financial Officer, Executive Vice President of Sales and Operations, Chief Operations Officer, Vice President of Trade and Director of Franchise Development, Vice President of Managed Markets and Strategy, and Vice President, respectively. The brand's market position rests on its 1986 founding, specialized service, franchise model, and recognition in alternate site infusion therapy.

Vital Care generally seeks experienced pharmacists, multi unit franchisees, and healthcare executives who can manage clinical operations, regulatory requirements, and patient care standards. The brand also targets buyers seeking to build multiple units. New development is focused on targeted and underserved U.S. markets. The 2024 FDD reported locations in 29 states, including 55 locations in the Southern region. The Southeast and Texas remain strategic areas, with notable concentrations in Georgia, North Carolina, and South Carolina. The source does not provide a timeline from signing to opening, franchise agreement term, renewal terms, transfer rules, or resale details.

Vital Care Infusion Services operates in a growing healthcare segment centered on care outside traditional hospitals. 5000 list, and more than 160 infusion pharmacy locations across 35 states as of August 2024. Berkshire Partners and Leonard Green & Partners announced a strategic investment in August 2024, while Linden Capital Partners remains an investor alongside management and the Bell family. Buyers should complete independent due diligence, including review of the FDD, market demand, staffing needs, capital requirements, and financial assumptions. PeerSense provides franchise research tools and data, including SBA lending history, Loan Activity Score, location maps with Google ratings, FDD financial data, and side by side comparison tools. PeerSense is a commercial capital advisory firm that introduces franchise buyers to SBA and conventional lenders and is not a lender.

According to its Franchise Disclosure Document or public business records, Vital Care Infusion Services has 110 locations. Cost figures are based on the 2025 Franchise Disclosure Document. To correct a figure, email the current FDD and the differing item numbers to info@peersense.com, and this page will be updated.

2025 FDD ON FILE

Est. 1986 · 110 locations

Investment

$555,750 to $1.0M

Franchise Fee

$60,000

Total Units

110

SBA Lending Activity for Vital Care Infusion Services

Loan Activity Score

This franchise has not yet been scored by the Franchise Performance Index. Scores are calculated based on public FDD data, SBA loan performance, and system level metrics.

Key Highlights

Item 19 financial data disclosed
110 locations nationwide

Data Insights

Key performance metrics for Vital Care Infusion Services based on SBA lending data

Investment Tier

Premium investment

$555,750 to $1,005,735 total

Why Vital Care Infusion Services Doesn't Appear in Public SBA Data

The SBA 7(a) program publishes loan level data for every approved franchise borrower. Vital Care Infusion Services does not currently appear in those public records, and that absence carries useful information for prospective franchisees evaluating this brand.

Absence from SBA records does not mean a brand is un fundable. It typically means the franchise system uses alternative capital sources, or that current franchisees self fund, secure conventional bank financing, or roll over equity from a prior business sale rather than going through an SBA guaranteed 7(a) loan. For prospective Vital Care Infusion Services franchisees, the practical question is which financing path actually closes for this brand's profile.

Data window: SBA 7(a) approvals reported through the most recent FOIA release. Absence of Vital Care Infusion Services from this window does not reflect lender denial. It reflects no 7(a)-program activity recorded for this brand in the public dataset.

Payment Estimator

Loan Amount$445K
Interest Rate9.5%
Term (Years)10 yr

Estimated Monthly Payment

$5,753

Principal & Interest only

Indicative only, as of November 1, 2026. Not a quote, commitment or offer of credit. Final pricing, leverage and terms are determined by the lender at underwriting, after full transaction materials are reviewed. PeerSense sources the file. The lender sets pricing. What these terms mean.

Locations

Vital Care Infusion Services, unit breakdown

Total Units
N/A
Franchisee Owned
n/a
System Owned
n/a
Closed
n/a

Explore Funding for Vital Care Infusion Services

Our business financing consultants help connect you with the right lending partners. Referral fee paid at closing.

Optional: checking the consent box lets us call or text you about your funding. You can still submit without it.

Referral fee at closing

Or get an instant analysis

Scan Your Deal Instantly

1 FDD Available for Vital Care Infusion Services

Review franchise fees, investment ranges, royalties, Item 19 financial data, and year over year trends. Request complimentary access through your PeerSense funding advisor.

Vital Care Infusion Services

Page Review

Reviewed by Edward L. Freeman, Founder and Managing Director, PeerSense

  • PeerSense is a capital advisory firm that places commercial financing with direct capital sources; the capital source sets final terms.
  • Edward L. Freeman founded PeerSense in January 2020.
  • He is a Registered Franchise Consultant with Business Alliance, Inc., a credential issued in March 2022, and worked as a franchise consultant there from March 2022 to May 2023.
  • His recorded experience includes a $22 million SBA construction loan, with about $16 million funded on the deal.
  • In the 12 months through September 30, 2026, PeerSense tracked 912 publicly announced financings with a disclosed size of $361.32 billion. PeerSense Capital Data Report · Methodology page

Last reviewed LinkedIn profileAbout Edward Freeman

This is not a franchise offering and does not constitute financial, investment, or legal advice. Data is sourced from Franchise Disclosure Documents (FDDs), public filings, and third party sources and may contain inaccuracies. The figures reflect the FDD on file for the year shown and may have been superseded or extracted with errors. PeerSense is not a financial advisor, attorney, or accountant. Always consult the brand's current FDD and seek professional guidance from a qualified attorney, accountant, or financial advisor before making any franchise investment decision. See full Terms & Conditions.